戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  strategies for vaccinating children against novel influenza A (H1N1) as well as seasonal influenza.
2                          A large outbreak of novel influenza A (H1N1) virus (swine origin influenza v
3                     In the spring of 2009, a novel influenza A (H1N1) virus (swine origin influenza v
4     This recent outbreak of infection with a novel influenza A (H1N1) virus also demonstrates the imp
5                     In the spring of 2009, a novel influenza A (H1N1) virus emerged in North America
6                                            A novel influenza A (H1N1) virus has spread rapidly across
7 atory during a springtime 2009 outbreak of a novel influenza A (H1N1) virus in New York State is desc
8 us on GBS when monovalent vaccines against a novel influenza A (H1N1) virus of swine origin were intr
9        Given the current worldwide threat of novel influenza A (H1N1), with an estimated R of 1.4-1.6
10                             The emergence of novel influenza A H1N1 and highly pathogenic avian influ
11  and recommendations for vaccination against novel influenza A have emerged as well.
12  virus host factor that may be targeted as a novel influenza A therapeutic strategy.
13                 We report the isolation of a novel influenza A virus (H2N2) cultured in 2013 from a h
14                         The emergence of the novel influenza A virus (IAV) H7N9 since 2013 has caused
15 hat poor performance in the detection of the novel influenza A virus 2009 H1N1 should preclude their
16 , understanding how orthomyxoviruses such as novel influenza A virus reassortants and/or mutants emer
17 provide partial protection to humans against novel influenza A virus strains introduced into humans f
18 efficiently among humans are essential for a novel influenza A virus to cause a pandemic.
19                        Human infections with novel influenza A viruses are of global public health co
20 re chemoprophylaxis of human infections with novel influenza A viruses associated with severe human i
21                                              Novel influenza A viruses of the H7N9 subtype [A(H7N9)]
22                                          The novel influenza A viruses of the H7N9 subtype [A(H7N9)],
23 f influenza and monitor for the emergence of novel influenza A viruses.
24                                     The 2009 novel influenza A(H1N1) pandemic period was excluded fro
25                             In March 2013, a novel influenza A(H7N9) virus emerged in China as an une
26                                          Two novel influenza A-like viral genome sequences have recen
27                    In this report, we used a novel Influenza A/California/04/09 (H1N1) reporter virus
28  data available describing human immunity to novel influenza A/H7N9.
29 phere winter of 2003-2004 the emergence of a novel influenza antigenic variant, A/Fujian/411/2002-lik
30 does this work describe the development of a novel influenza assay, it also demonstrates the power of
31 tion options should initial containment of a novel influenza outbreak fail, using Great Britain and t
32          Because of the continuous threat of novel influenza outbreaks, it is essential to gather fur
33                 Following the detection of a novel influenza strain A(H7N9), we modeled the use of an
34                Humans, upon infection with a novel influenza strain, produce Abs against older viral
35 rrectly identify both well-characterized and novel influenza strains offers the possibility to integr
36           In the context of recently emerged novel influenza strains through reassortment, avian infl
37 e valid predictions of pandemic potential of novel influenza strains, though results should continue
38 ts in studying the transmission potential of novel influenza strains.
39 ody produced in response to vaccines against novel influenza strains.
40                         In theory, a similar novel influenza subtype could be controlled.
41   In the pig, genetic reassortment to create novel influenza subtypes by mixing avian, human, and swi
42 ccur in coincident temporal association with novel influenza vaccination.
43                                          The novel influenza vaccine MVA-NP+M1 is designed to boost c
44 replication-incompetent NS2-knockout VLPs as novel influenza vaccines and perhaps also as vectors to
45 lly catastrophic influenza pandemic requires novel influenza vaccines that are safe, can be produced
46     Direct comparisons of similar doses of a novel influenza virus antigen administered by the intrad
47                             The frequency of novel influenza virus detection is increasing, and human
48 nd transmission of and approaches to prevent novel influenza virus infections.
49                            The potential for novel influenza virus lineages to evolve within Africa w
50                                A-315675 is a novel influenza virus NA inhibitor that has potent enzym
51 rge-scale sequencing effort, we identified a novel influenza virus of wholly human origin that has be
52             Over the past 2 decades, several novel influenza virus proteins have been identified that
53                           Here we describe a novel influenza virus sequence feature variant type (Flu
54 asurement used for identifying antigenically novel influenza virus strains.
55               Influenza D virus (FLUDV) is a novel influenza virus that infects cattle and swine.
56  increase the chances for the emergence of a novel influenza virus with pandemic potential.
57                                            A novel influenza virus, tentatively classified as influen
58 ldren are susceptible to infection with this novel influenza virus.
59 gations for future pandemics or outbreaks of novel influenza viruses among humans.
60 other respiratory pathogens will help detect novel influenza viruses and inform and develop targeted
61               Influenza pandemics arise when novel influenza viruses are introduced into a population
62 eems wise to conduct better surveillance for novel influenza viruses at Chinese live bird markets.
63 ual circulation of seasonal influenza, while novel influenza viruses invade the human population to c
64 blic health threat posed by the emergence of novel influenza viruses necessitates the ability to rapi
65                             The emergence of novel influenza viruses that cause devastating human dis
66  to monitor H7N9 and detect other unexpected novel influenza viruses that may emerge.
67 ant parameter in evaluating the virulence of novel influenza viruses, and findings are extrapolated t
68 in-specific or cross-protective vaccines for novel influenza viruses.
69 e future surveillance and risk assessment of novel influenza viruses.
70 dren are highly vulnerable to infection with novel influenza viruses.
71 says commonly used to identify antigenically novel influenza viruses.
72 ddress humans as hosts for the generation of novel influenza viruses.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。